TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Yang, Li, Pang, Yanli, Moses, Harold L.·2010·Trends in Immunology
DOI 10.1016/j.it.2010.04.002

Cited by (1,000)

Items 701–800 of 1,000

  1. The Emerging Role of CD8+ T Cells in Shaping Treatment Outcomes of Patients with MDS and AML
    Athanasios Tasis, Theodoros Spyropoulos, Ioannis Mitroulis · 2025 · Cancers
  2. Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment
    ISRAR AHMAD KHAN, Qiujie Fang, Cao Fei, Ziyuan Wang, Zhaowei Chen, Guojun Chen, Zhiming Xu, Shuhua Xu, Zhitong Chen · 2025 · BMEMat
  3. The activation of TGF-β signaling promotes cell migration and invasion of ectopic endometrium by targeting NRP2
    Tian Gao, Yi Cao, Min Shan Hu, Ying Du · 2022 · Reproductive Biology
  4. The Two Faces of Angiopoietin‐Like Protein 2 in Cancer
    Haruki Horiguchi, Tsuyoshi Kadomatsu, Yuichi Oike · 2024 · Cancer Science
  5. Long-Acting Tumor-Activated Prodrug of a TGFβR Inhibitor
    Yong Zhang, Karen E. Parrish, David R. Tortolani, Michael A. Poss, Audris Huang, Honghe Wan, Ashok V. Purandare, Andrew F. Donnell, James Kempson, Xiaoping Hou et al. · 2021 · Journal of Medicinal Chemistry
  6. Paradoxical Radiosensitizing Effect of Carnosic Acid on B16F10 Metastatic Melanoma Cells: A New Treatment Strategy
    Miguel Alcaraz, Amparo Olivares, Marina Andreu-Gálvez, Daniel Gyingiri Achel, Ana María Mercado, Miguel Alcaraz-Saura · 2022 · Antioxidants
  7. 5-Aza-2′-Deoxycytidine (5-Aza-dC, Decitabine) Inhibits Collagen Type I and III Expression in TGF-β1-Treated Equine Endometrial Fibroblasts
    Joana Alpoim‐Moreira, Anna Zuzanna Szóstek-Mioduchowska, Magda Słyszewska, Maria Rosa Rebordão, Dariusz Jan Skarzynski, Graça M. Ferreira-Dias · 2023 · Animals
  8. Prediction of Tumor Microenvironment Characteristics and Treatment Response in Lung Squamous Cell Carcinoma by Pseudogene OR7E47P-related Immune Genes
    Yaqi Zhao, Hao-han Zhang, Jie Wu, Lan Li, Jing Li, Hao Zhong, Yan Jin, Tianyu Lei, Xinyi Zhao, Bin Xu et al. · 2023 · Current Medical Science
  9. Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo Model
    Philippe Collery, Chloé Prunier, Emilien Dosda, Jean P. Viallet, Adhikesavan Harikrishnan, V. Veena, Didier Desmaële · 2024 · Anticancer Research
  10. Ustekinumab therapy changes the transcriptional activity pattern of TGF-β1–3 genes
    Beniamin Oskar Grabarek, Dominika Ligia Wcisło-Dziadecka, Barbara Strzałka‐Mrozik, Joanna Magdalena Gola, Andrzej Plewka · 2019 · Advances in Dermatology and Allergology
  11. Local Immune Changes in Early Stages of Inflammation and Carcinogenesis Correlate with the Collagen Scaffold Changes of the Colon Mucosa
    Fabián Čaja, Dmitry Stakheev, Oleksandr Chernyavskiy, Lucie Kubínová, J Křižan, Jiří Dvořák, Pavel Rossmann, Renáta Štëpánková, Peter Makovický, Pavol Makovický et al. · 2021 · Cancers
  12. Advance of T regulatory cells in tumor microenvironment remodeling and immunotherapy in pancreatic cancer
    Zetian Gao, Qiubo Zhang, Xie Zhang, Yufei Song · 2022 · European Journal of Inflammation
  13. Transforming Growth Factor-Beta1 and Myeloid-Derived Suppressor Cells Interplay in Cancer
    Juan Francisco Santibanez, Suncica Bjelica · 2017 · The Open Cancer Immunology Journal
  14. Mesenchymal traits at the convergence of tumor-intrinsic and -extrinsic mechanisms of resistance to immune checkpoint blockers
    Paola Trono, Antonella Sistigu, Belinda Palermo, Gennaro Ciliberto, Paola Nisticò · 2017 · Emerging Topics in Life Sciences
  15. Prognostic value of the pretreatment neutrophil‑to‑lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure
    Paweł Sobczuk, Paweł Teterycz, Iwona A. Lugowska, Anna Klimczak, Elżbieta Bylina, Anna Malgorzata Czarnecka, Hanna Koseła-Paterczyk, Czesław Osuch, Joanna Streb, Piotr Lukasz Rutkowski · 2019 · Oncology Letters
  16. Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment
    Na Tang, Lei Cheng, Jiawei Hao, Beilei Xu, Xi Pan, Xiaofei Wei, Hao Wu, Haoyi Wang · 2025 · Acta Neuropathologica Communications
  17. Medicinal Chemistry Strategies in Targeting TGF-βR1 Kinase Domain: Unveiling Insights into Inhibitor Structure–Activity Relationship (SAR)
    Nusaiba A. Babiker, Soam Nadeem, Hasan Abu Kariem, Afra Abdul Hameed, Ahmed T. Negmeldin, Eman M. El‐labbad · 2025 · Pharmaceuticals
  18. Co-delivery nanoparticle targeting CAF for simultaneous activating T cell plus NKT cell attack in solid tumor
    Yucheng Xiang, Lie Zhang, Jing Ye, Yu Chen, Qiao Ren, Bingyin Su, Xiaohong Xu, Quan Zhang · 2026 · Journal of Advanced Research
  19. Molecular characterization, expression and immune functional analysis of cystatin 10 in turbot
    Fan Zhang, Zhixiang Duan, Qiannan Chen, Xuangang Wang, Hengshun Li, Ze Tao, Zhentao Chen, Gan Yu, Haiyang Yu · 2024 · Molecular Biology Reports
  20. Engineered extracellular vesicles for TGF-β encapsulation as a therapeutic strategy against LPS-induced systemic inflammation
    Zhuo-Hua Zhao, Bo Huang, Zi-Han Fang, Wen-Hui Qi, Jinpeng He, Li‐Bin Wang, Yuan Zhang, Xing Li · 2025 · International Immunopharmacology
  21. Stromal TGFβR2 signaling: a gateway to progression for pancreatic cancer
    Moriah M. Hagopian, Rolf A. Brekken · 2014 · Molecular & Cellular Oncology
  22. A homologue of dermatopontin fromHaliotis diversicolorand its response to pathogenic infection
    Guodong Wang, Ziping Zhang, Shi Lin, Lili Zhang, Baozhen Wang, Shuhong Wang, Yilei Wang · 2013 · Aquaculture Research
  23. A Proliferation-Inducing Ligand Regulation in Polymorphonuclear Neutrophils by Panax ginseng
    Wioletta Ratajczak–Wrona, Natalia Wawrusiewicz‐Kurylonek, Marzena Garley, Adam Jacek Kretowski, Ewa Jabłońska · 2020 · Archivum Immunologiae et Therapiae Experimentalis
  24. Response Challenges to Cancer Immunotherapies
    Ismail Ibrahim Al-Janabi · 2022 · Al-Rafidain Journal of Medical Sciences
  25. The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers
    Ava Saidian, Isabella M Dolendo, Andrew B. Sharabi, Tyler Francis Stewart, Brent Rose, Rana R. McKay, Aditya Bagrodia, Amirali Salmasi · 2022 · Cancers
  26. Development and validation of an inflammatory response-related prognostic model and immune infiltration analysis in glioblastoma
    Wenjun Zhu, Na Luo, Qianxia Li, Xin Chen, Xiaoyu Li, Min Fu, Feng Yang, Ziqi Chen, Yiling Zhang, Yuanyuan Zhang et al. · 2023 · Annals of Translational Medicine
  27. p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction
    Derek P. Wong, Claire E. Fritz, Daniel M. Feinberg, Alex Yee-Chen Huang, Reshmi Parameswaran · 2023 · Cancer Research Communications
  28. The interplay between the epithelial permeability barrier, cell migration and mitochondrial metabolism of growth factors and their inhibitors in a human endometrial carcinoma cell line
    Takumi Konno, Takayuki Kohno, Shin Kikuchi, Arisa Kura, Kimihito Saito, Tadahi Okada, Hiroshi Shimada, Yuya Yamazaki, Tomoki Sugiyama, Motoki Matsuura et al. · 2024 · Tissue Barriers
  29. hAMSCs regulate EMT in the progression of experimental pulmonary fibrosis through delivering miR-181a-5p targeting TGFBR1
    Yanyang Wang, Chan Liu, Nuoxin Wang, Dong Weng, Yan Zhao, Hongyu Yang, Haoyuan Wang, Shangfu Xu, Jianmei Gao, Changhui Lang et al. · 2025 · Stem Cell Research & Therapy
  30. Regulatory T Cell Mimicry by a Subset of Mesenchymal GBM Stem Cells Suppresses CD4 and CD8 Cells
    Amanda Johnson, Harmon Singh Khela, Jack Korleski, Sophie Sall, Yunqing Li, Weiqiang Zhou, Karen Smith-Connor, John Laterra, Hernando López-Bertoni · 2025 · Cells
  31. Downregulation of transforming growth factor-β2 enhances the chemosensitivity to gemcitabine with diminished metastasis in pancreatic cancers
    Dohee Ahn, Hong Kyu Lee, Sang Hyeok Bae, Hwayoung Na, Kyung‐Chul Choi · 2025 · Biomedicine & Pharmacotherapy
  32. Inhibition of PI3 Kinase Gamma Enzyme by Novel Phenylpyrazoles
    Sukumar Bepary, In Kwon Youn, Hee‐Jong Lim, Ge Hyeong Lee · 2013 · Bulletin of the Korean Chemical Society
  33. Inflammation-related cancer or cancer-related inflammation
    Shrihari T.g · 2017 · The European Research Journal
  34. Advancing neuro-oncology of glial tumors from big data and multidisciplinary studies
    Chin‐Hsing Annie Lin, Mitchel Stuart Berger · 2019 · Journal of Neuro-Oncology
  35. The Prognostic Value of a Tumor Microenvironment-Based Immune Cell Infiltration Score Model in Colon Cancer
    Xingkui Tang, Minling Liu, Xijun Luo, Mengyuan Zhu, Shan Huang, Xiaofen Pan · 2021 · Frontiers in Oncology
  36. Molecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens
    Kobe Chi Yung Yuen, Ben Tran, Angelyn Anton, Habib Hamidi, Anthony J. Costello, Niall M. Corcoran, Nathan Lawrentschuk, Natalie Heather Rainey, Marie C. Semira, Peter Gibbs et al. · 2022 · The Prostate
  37. Immune signaling-based Cascade Propagation approach re-stratifies HNSCC patients
    Keqin Liu, Jacqueline Chyr, Weiling Zhao, Xiaobo Zhou · 2016 · Methods
  38. Natural Compounds as New Cancer Treatments
    Enrique Barrajón‐Catalán · 2019 · Medicines
  39. Transforming growth factor‐beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase‐9 expression in mouse macrophages; analysis of intracellular signal transduction
    Sonja S. Mojsilović, Juan Francisco Santibanez · 2015 · Cell Biology International
  40. Toll‐Like Receptors: Role in Inflammation and Cancer
    Sarang Tartey, Osamu Takeuchi · 2014 · Wiley eBooks
  41. Tumor-associated stroma shapes the spatial tumor immune microenvironment of primary Ewing sarcomas
    Christopher Kuo, Krinio Giannikou, N.-K. Wang, Mikako Warren, Andrew E. Goodspeed, Nick Shillingford, Masanori Hayashi, Micha Sam Brickman Raredon, James F. Amatruda · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  42. The Role of Fibroblasts in Melanoma Development: From Tumor Microenvironment Remodeling to Pre-Metastatic Niche Formation
    Immacolata Belviso, Raffaele Pastore, Aldo Mileo, Emiliano Del Genio, Stefania Boccia, Stefano Palermi, Carmine Sellitto, Maria Letizia Motti · 2025 · International Journal of Molecular Sciences
  43. Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies
    Sara Sadeghzadeh, Razieh Ebrahimi Askari, Aysan Zareiye, Ahmad Meshkin, Reyhaneh Aghabozorgi, Marzieh Lotfi, Fahimeh Ghanbari, Seyed Hossein Shahcheraghi, Zahra Sadat Aghili · 2025 · Brain Tumor Pathology
  44. Individual subsets of alternatively-activated macrophages differentially contribute to tissue repair and the resolution of inflammation
    Katharina Knab, Jochen A. Ackermann, Philipp Burger, David Chambers, Karolina Grimm, Rita Weinkam, Alexandra Correa Zamora, Jean-Philippe Auger, Benjamin Frey, Georg Andreas Schett et al. · 2025 · The Journal of Immunology
  45. SMAD signaling in cancer: integrative roles in tumor progression, immune evasion, and therapeutic resistance
    Hai Zhao, Fan Yang, Jiaxin Yang, Sheng Yang · 2025 · Cytokine
  46. Double, double toil and trouble: transforming growth factor beta (TGF-β) in HIV infection
    Jakob Harrison-Gleason, Kayla L Yerlioglu, Ariel W T Halle, Judd F. Hultquist, Elena Martinelli · 2026 · Frontiers in Immunology
  47. TGF-β–YY1 signaling as a key driver of immune evasion in pancreatic cancer: Therapeutic implications
    Mai P. Ho, Megan Jung, William Ung, Evagelia Skouradaki, Stavroula Baritaki, Benjamin Bonavida · 2026 · Cytokine & Growth Factor Reviews
  48. Bridging Cancer and COVID ‐19: The Complex Interplay of ACE2 and TMPRSS2
    Xuerui Tang, Liuzhi Lu, Xiaoping Li, Panpan Huang · 2025 · Cancer Medicine
  49. The crosstalk of breast cancer and ischemic heart disease
    Yunbo Luo, Jun Liu, Peng Qu, Shiqi Han, Xue Li, Yali Wang, Xiaohan Su, Jiao Zeng, Jinsui Li, Shishan Deng et al. · 2025 · Cell Death Discovery
  50. A stroma szerepe a tumorok kialakulásában és progressziójában
    Marcell Baranyi, Mónika Lippai, Zsuzsanna Szatmári · 2015 · Orvosi Hetilap
  51. Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinoma
    Haolin Song, Chen Jiang · 2022 · Expert Opinion on Drug Delivery
  52. Investigation of the Ability of Crocin to Treat Skin Cancer Chemically Induced in Mice via the Inhibition of the Wnt/β-Catenin and Fibrotic Pathway
    Abdullah Alyoussef · 2023 · Cureus
  53. Evaluating targeted therapies in older patients with TP53 -mutated AML
    Jean M.G. Sabile, Ronan T. Swords, Jeffrey W Tyner · 2024 · Leukemia & lymphoma/Leukemia and lymphoma
  54. Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancers
    Alessandro Prete, Carmelo Nucera · 2024 · Current Opinion in Endocrine and Metabolic Research
  55. Assessing TGF-β Prognostic Model Predictions for Chemotherapy Response and Oncogenic Role of FKBP1A in Liver Cancer
    Weimei Chen, Qinghe Que, Rongrong Zhong, Lin Zhou, Qiaolan Yi, Qingshui Wang · 2024 · Current Pharmaceutical Design
  56. Tumor-promoting effect and tumor immunity of SRSFs
    Shuai Zhang, Yongxi Zhang, Sijia Feng, Miaomiao Han, Zixi Wang, Dan Qiao, Jiaqi Tian, Lan Wang, Baoshun Du, Zheying Zhang et al. · 2025 · Frontiers in Cell and Developmental Biology
  57. Immune Cell Dysfunction as a Consequence of Severe Sepsis
    William F. Carson, Steven L. Kunkel · 2012 · InTech eBooks
  58. Remodeling the Irradiated Tumor Microenvironment: The Fifth R of Radiobiology?
    Mary Helen Barcellos‐Hoff · 2016 · Cancer drug discovery and develogment/Cancer drug discovery and development
  59. MORPHO-FUNCTIONAL CHANGES OF THYMUS AND CONTENTS OF BLOOD LYMPHOCYTE SUBPOPULATIONS IN FEMALE WISTAR RATS WITH DIFFERENT RESISTANCE TO HYPOXIA IN SYSTEMIC INFLAMMATORY RESPONSE
    Anna Mikhailovna Kosyreva, Dzhuliia Sh. Dzhalilova, Olga V. Makarova, A. S. Sladkopevtsev · 2019 · Medical Immunology (Russia)
  60. Betulin Attenuates TGF-β1- and PGE2-Mediated Inhibition of NK Cell Activity to Suppress Tumor Progression and Metastasis in Mice
    Masaru Ogasawara, Shino Yamasaki-Yashiki, Masahiro Hamada, Tomomi Yamaguchi-Miyamoto, Toru Kawasuji, Hiroe Honda, Tsutomu Yanagibashi, Masashi Ikutani, Yasuharu Watanabe, Ryota Fujimoto et al. · 2022 · Biological and Pharmaceutical Bulletin
  61. Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma
    Yamin Jie, Jianing Wu, Dongxue An, Man Li, Hongjiang He, Duo Wang, Anxin Gu, E Mingyan · 2023 · Frontiers in Pharmacology
  62. The Stressful Life of Cardiac Myofibroblasts
    Elena Zimina, Boris Hinz · 2015 · Springer eBooks
  63. The return of Dr Jekyll in cancer metastasis
    Liliana Attisano, Jeffrey L. Wrana · 2012 · The EMBO Journal
  64. Discovery of Novel Small Molecules that Block Myofibroblast Formation: Implications for Capsular Contracture Treatment
    Rachel H. Park, Stephen J. Pollock, Richard P. Phipps, Howard N. Langstein, Collynn F. Woeller · 2019 · Plastic & Reconstructive Surgery Global Open
  65. Prognostic impact of lncRNA-ATB expression in malignant solid tumors: A meta-analysis
    Bolin Wang, Zhong Lü, Yan Huang, Tao Lin · 2020 · Pathology - Research and Practice
  66. Elucidation of natural compounds Gallic acid and Shikonin for the treatment of HNSC cancer by targeting immune suppressor and tumour progressor genes
    Sunil Kumar, Asmita Das · 2022 · Vegetos
  67. Combinatorial islet protective therapeutic approaches in β‐cell transplantation: Rationally designed solutions using a target product profile
    Katie Lu, Timothy A. Brauns, Ann E. Sluder, Mark C. Poznansky, Fatma Doğan · 2023 · FASEB BioAdvances
  68. Severe recalcitrant morbilliform eruption from dual immune checkpoint blockade
    Sakeena Fatima, Jesse J. Veenstra, Albert S. Antonyan, Laurie Linden Kohen · 2018 · JAAD Case Reports
  69. Dementia risk genes engage gene networks poised to tune the immune response towards chronic inflammatory states
    Jessica E. Rexach, Vivek Swarup, Timothy S. Chang, Daniel H. Geschwind · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Evaluation of Novel Therapeutic Agents for Modulation of the Inflammatory Response in Rotator Cuff Tendinopathy Utilizing a Mouse Model of Subacromial Impingement
    Claire D. Eliasberg, Camila B. Carballo, Vincent J.H. Yao, Alexander N. Piacentini, Leonardo Albertini Sanchez, Thomas Morgan Li, Janice Havasy, Edward G. Bowen, Marjan Khan, Scott Alan Rodeo · 2025 · The American Journal of Sports Medicine
  71. Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment
    Geling Teng, Min Zhang, Yu‐Ling Pan, Sajad Karampoor, Rasoul Mirzaei · 2025 · Open Life Sciences
  72. Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients
    Lara Rosaline Heij, Sikander Hayat, Konrad Reichel, Sidrah Maryam, Colm J. O’Rourke, Xiuxiang Tan, Marlous van den Braber, Jan Verhoeff, Maurice Halder, Fabian Peisker et al. · 2026 · npj Precision Oncology
  73. Characterizing tumor microenvironment heterogeneity in EBV+ nTNKL vs ENKTL using spatial transcriptomics and MIF
    Siyu Qian, ZeYuan Wang, Yue Zhang, Wanyue Zhao, Honghan Qiao, Xiaoyan Feng, Yukai Duan, Boyuan Su, Shifeng Hao, Zhenzhen Yang et al. · 2026 · Frontiers in Immunology
  74. TGF-β in hematologic malignancies: molecular functions and clinical applications
    Ruiyang Li, Wei Fang, Yang Ml · 2026 · Frontiers in Immunology
  75. Enhancing DOX efficacy against NSCLC through UDCA-mediated modulation of the TGF-β/MAPK autophagy pathways
    Ying Li, Helian Zhao, Zhoumin Shen, Yao Zheng, Yuanyuan Jiang, Ying Song, Yimin Cai · 2024 · Scientific Reports
  76. Discovery of paradoxical genes: reevaluating the prognostic impact of overexpressed genes in cancer
    Dequan Liu, Lei Liu, Xiangyu Che, Guangzhen Wu · 2025 · Frontiers in Cell and Developmental Biology
  77. Dual-Faced Role of GDF6 in Cancer: Mechanistic Insights into Its Context-Dependent Regulation of Metastasis and Immune Evasion Across Human Malignancies
    Qi Zhu, Jianshu Wei, Weidong Han · 2025 · Current Issues in Molecular Biology
  78. PET/CT imaging of esophageal cancer targeting tumor cell specific αvβ6-integrin expression
    Kateřina Dvořáková Bendová, Tanja Groll, Barbora Neužilová, Kristýna Krasulová, Zbyněk Nový, Falco Reissig, Katja Steiger, Melanie Boxberg, Elisabeth Eppard, Jan Wuestemann et al. · 2025 · European Journal of Nuclear Medicine and Molecular Imaging
  79. Tumour immune cell infiltration and response to FOLFOX or FOLFIRI chemotherapy in colorectal cancer
    Jia Feng, Lei Zhang, Zhijun Liao, You Feng Zou, Rong Liu · 2026 · The Pharmacogenomics Journal
  80. Involvement of transforming growth factor beta-1 (TGFβ1) cytokine and FOXP3 transcription factor genetic polymorphisms in hematological malignancies
    Glauco Akelinghton Freire Vitiello, Roberta Losi Guembarovski, Carlos Eduardo Coral de Oliveira, Marla Karine Amarante, Aparecida de Lourdes Perim, Maria Angélica Ehara Watanabe · 2015 · Brazilian Archives of Biology and Technology
  81. Irinotecan or Oxaliplatin: Which is the First Move for the Mate?
    Cristina Morelli, Vincenzo Formica, Silvia Riondino, Antonio Dello Russo, Patrizia Ferroni, Fiorella Guadagni, Mario Roselli · 2020 · Current Medicinal Chemistry
  82. The underlying metabolism of hypoalbuminemia and its clinical effects
    Peter B. Soeters, Peter W. de Leeuw · 2021 · Elsevier eBooks
  83. Characterization of in vitro 3D cultures
    Nabi Mousavi · 2021 · Apmis
  84. Identification of Immune Function-Related Subtypes in Cutaneous Melanoma
    Lin Liu, Junkai Zhu, Tong Jin, Mengjia Huang, Yi Chen, Li Xu, Wenxuan Chen, Bo Jiang, Fangrong Yan · 2021 · Life
  85. TGFβ1 pathway components in breast cancer tissue from aggressive subtypes correlate with better prognostic parameters in ER-positive and p53-negative cancers
    Glauco Akelinghton Freire Vitiello, Marla Karine Amarante, Jefferson Crespigio, Bruna Karina Banin Hirata, Nathália de Sousa Pereira, Karen Brajão de Oliveira, Roberta Losi Guembarovski, Maria Angélica Ehara Watanabe · 2021 · Surgical and Experimental Pathology
  86. Molecules involved in the development of Barrett’s esophagus phenotype in chronic eosinophilic esophagitis
    Sathisha Upparahalli Venkateshaiah, Chandra Sekhar Yadavalli, Hemanth Kumar Kandikattu, Sandeep Kumar, Lokanatha Oruganti, Anil Mishra · 2022 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  87. A mathematical model with aberrant growth correction in tissue homeostasis and tumor cell growth
    Haifeng Zhang, Meirong Zhang, Jinzhi Lei · 2022 · Journal of Mathematical Biology
  88. It Takes Two to Tango: The Interplay between Prostate Cancer and Its Microenvironment from an Epigenetic Perspective
    Anniek Zaalberg, Elisabeth Pottendorfer, Wilbert T. Zwart, Andries Marinus Bergman · 2024 · Cancers
  89. A heterogeneous tumor immune microenvironment of uncommon epidermal growth factor receptor mutant non‐small cell lung cancer
    Chong Zhang, Liangwei Yang, Weidi Zhao, Huangkai Zhu, Shuo Shi, Songan Chen, Guoqiang Wang, Bing Li, Guofang Zhao · 2024 · Cancer Science
  90. Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis
    Julio Valdivia‐Silva, Alberto Chinney-Herrera · 2024 · International review of cytology
  91. CRISPR/Cas9 Technology for Modifying Immune Checkpoint in CAR-T Cell Therapy for Hematopoietic Malignancies
    Forough Shams, Elham Sharif, Hajar Abbasi‐Kenarsari, Nader Hashemi, Masoumeh Sadat Hosseini, Neda Heidari, Effat Noori, Ali Hossein Amini, Maryam Bazrgar, Maryam Rouhani et al. · 2025 · Current Gene Therapy
  92. Novel Biomimetic Microphysiological Systems for Tissue Regeneration and Disease Modeling
    Karim I. Budhwani, Patsy G. Oliver, Donald J. Buchsbaum, Vinoy Thomas · 2018 · Advances in experimental medicine and biology
  93. Changes in bone mineral density, 25‑hydroxyvitamin D3 and inflammatory factors in patients with hyperthyroidism
    Zhou Yali, Xixia Wang, Maoyuan Xin, Haiting Zhuang · 2021 · Experimental and Therapeutic Medicine
  94. Nitric oxide and derivatives: Molecular insights and translational opportunities
    Braian Rene Ledesma, Fakiha Firdaus, Maria Silena Mosquera, Katherine Campbell, Farah Rahman, María Camila Suarez Arbeláez, Himanshu Arora · 2023 · Elsevier eBooks
  95. Novel Insights Into the Role of Inflammation in Promoting Breast Cancer Development
    Julio Valdivia‐Silva, Janusz Franco‐Barraza, Edna Cukierman, E.A. Garcia-Zepe · 2011 · InTech eBooks
  96. CELLULAR AND MOLECULAR MECHANISMS OF LIVER FIBROGENESIS
    Elena Ivanovna Lebedeva, O. D. Myadelets · 2019 · Hepatology and Gastroenterology
  97. Pharmacodynamics‐based approach for efficacious human dose projection of BMS‐986260, a small molecule transforming growth factor beta receptor 1 inhibitor
    Karen E. Parrish, Jesse Swanson, Lihong Cheng, Emily Luk, Paul I. Stetsko, James Smalley, Yue‐Zhong Shu, Jinwen Huang, Jonathan G. Pabalan, Yongnian Sun et al. · 2020 · Biopharmaceutics & Drug Disposition
  98. Transcriptional repression of the tyrosinase-related protein 2 gene by transforming growth factor-β and the Kruppel-like transcription factor GLI2
    Marie‐Jeanne Pierrat, Véronique Marsaud, Alain Mauviel, Delphine Javelaud · 2019 · Journal of Dermatological Science
  99. Dietary Fiber and Cancer
    Marilena Antunes‐Ricardo, Javier Villela Castrejon, Janet Alejandra Gutierrez-Uribe, Sergio Othón Serna-Saldivar · 2020 · Food engineering series
  100. Immuno-genomic PanCancer Landscape Reveals Diverse Immune Escape Mechanisms and Immuno-Editing Histories
    Shinichi Mizuno, Rui Yamaguchi, Takanori Hasegawa, Shuto Hayashi, Masashi Fujita, Fan Zhang, Youngil Koh, Su‐Yeon Lee, Sung‐Soo Yoon, Eigo Shimizu et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)